Bionik Laboratories Corp Stock OTC Bulletin Board
Equities
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
2023 | Bionik Laboratories Corp. Announces Executive Changes | CI |
2023 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
Sales 2022 | 1.27M 1.74M | Sales 2023 | 1.81M 2.46M | Capitalization | 2.8M 3.81M |
---|---|---|---|---|---|
Net income 2022 | -10M -13.64M | Net income 2023 | -4M -5.46M | EV / Sales 2022 | 0.17 x |
Net cash position 2022 | 1.99M 2.72M | Net Debt 2023 | 1.98M 2.71M | EV / Sales 2023 | 2.65 x |
P/E ratio 2022 |
-0.21
x | P/E ratio 2023 |
-0.56
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 20% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Russo
CEO | Chief Executive Officer | 44 | 20-11-29 |
Michal Prywata
FOU | Founder | 33 | 10-01-07 |
Dan Gonsalves
DFI | Director of Finance/CFO | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michal Prywata
FOU | Founder | 33 | 10-01-07 |
Director/Board Member | 68 | 17-08-31 | |
Richard Russo
CEO | Chief Executive Officer | 44 | 20-11-29 |
1st Jan change | Capi. | |
---|---|---|
-5.51% | 182B | |
+2.33% | 111B | |
-3.62% | 68.48B | |
+1.52% | 49.69B | |
+8.06% | 44.46B | |
+5.53% | 40.67B | |
+23.35% | 31.22B | |
+0.67% | 26.09B | |
+17.96% | 25.32B |